OM
NASDAQOutset Medical Inc.
News · 26 weeks63+45%
2025-12-142026-06-07
Mix3290d
- Insider14(44%)
- Other9(28%)
- SEC Filings7(22%)
- Leadership1(3%)
- Earnings1(3%)
Latest news
25 items- INSIDERDirector Hackett Patrick T was granted 10,667 shares, increasing direct ownership by 11% to 105,839 units (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDERDirector Oboyle Kevin C was granted 10,667 shares, increasing direct ownership by 44% to 34,785 units (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDERDirector Prange Karen was granted 10,667 shares, increasing direct ownership by 57% to 29,334 units (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDERDirector Lang Brent D. was granted 10,667 shares, increasing direct ownership by 60% to 28,518 units (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDERDirector Grossman D Keith was granted 10,667 shares, increasing direct ownership by 77% to 24,585 units (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDERDirector Drexler Karen was granted 10,667 shares, increasing direct ownership by 100% to 21,317 units (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDERChief Financial Officer Gaeta Renee sold $87,300 worth of shares (17,672 units at $4.94), decreasing direct ownership by 13% to 113,753 units (SEC Form 4) (for withholding tax)4 - Outset Medical, Inc. (0001484612) (Issuer)
- SECOutset Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Outset Medical, Inc. (0001484612) (Filer)
- SECOutset Medical Inc. filed SEC Form 8-K: Leadership Update8-K - Outset Medical, Inc. (0001484612) (Filer)
- SECSEC Form SD filed by Outset Medical Inc.SD - Outset Medical, Inc. (0001484612) (Filer)
- PROutset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)SAN JOSE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ:OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the "Company"), today announced that the Compensation Committee of its Board of Directors approved equity awards under the Company's Inducement Plan, as a material inducement to employment to two newly appointed non-executive employees, in each case, who were not previous employees or directors of the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of any equity awards that are not
- INSIDERChair and CEO Trigg Leslie sold $12,746 worth of shares (3,445 units at $3.70), decreasing direct ownership by 3% to 98,874 units (SEC Form 4) to satisfy tax liability4 - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDEREVP Operations R&D & Service Nash Marc sold $5,853 worth of shares (1,582 units at $3.70), decreasing direct ownership by 4% to 38,393 units (SEC Form 4) (tax withholding)4 - Outset Medical, Inc. (0001484612) (Issuer)
- INSIDERGeneral Counsel Brottem John L. sold $9,761 worth of shares (2,638 units at $3.70), decreasing direct ownership by 8% to 30,277 units (SEC Form 4) (for withholding tax)4 - Outset Medical, Inc. (0001484612) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Outset Medical Inc.SCHEDULE 13G/A - Outset Medical, Inc. (0001484612) (Subject)
- INSIDERLarge owner Leonard Braden Michael exercised 323,000 in-the-money shares at a strike of $5.00 (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- SECSEC Form 144 filed by Outset Medical Inc.144 - Outset Medical, Inc. (0001484612) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Outset Medical Inc.SCHEDULE 13G/A - Outset Medical, Inc. (0001484612) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Outset Medical Inc.SCHEDULE 13G/A - Outset Medical, Inc. (0001484612) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Outset Medical Inc.SCHEDULE 13G/A - Outset Medical, Inc. (0001484612) (Subject)
- INSIDERLarge owner Leonard Braden Michael exercised 294,500 in-the-money shares at a strike of $5.00 (SEC Form 4)4 - Outset Medical, Inc. (0001484612) (Issuer)
- PROutset Medical to Present at RBC Global Healthcare ConferenceSAN JOSE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ:OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced that members of management will participate at the RBC Capital Markets Global Health Care conference on Tuesday, May 19, 2026, at 10:30 a.m. Eastern time. The live and archived webcast of the session will be available on the "Investors" section of the Outset website at https://investors.outsetmedical.com/. About Outset Medical, Inc.Outset is a medical technology company transforming the dialysis experience across the continuum of care wi
- SECSEC Form 10-Q filed by Outset Medical Inc.10-Q - Outset Medical, Inc. (0001484612) (Filer)
- SECOutset Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Outset Medical, Inc. (0001484612) (Filer)
- PROutset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026SAN JOSE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ:OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced that it will release financial results for the first quarter 2026 after the close of trading on Thursday, May 7, 2026. On the same day, at 1:30 p.m. Pacific time (4:30 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Renee Gaeta, Chief Financial Officer, will host a conference call to discuss financial and operating results. Conference Call DetailsThe conference call will begin at 1:30 p.m. Pacific time (4:30 p.
OM FAQ
7 questionsWhat does Outset Medical Inc. do?
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.Where does OM stock trade?
Outset Medical Inc. (OM) is listed on NASDAQ.What sector and industry is OM in?
Outset Medical Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.When did Outset Medical Inc. go public?
Outset Medical Inc. (OM) completed its IPO in 2020.What are analysts saying about OM?
Outset Medical Inc. has had 8 recent analyst actions on file. The most recent action was from RBC Capital Mkts: Sector Perform with a $300.00 price target on 2024-08-08.What companies are similar to OM?
Notable peers in the same industry include MDT (Medtronic plc.), MASI (Masimo Corporation), SEAS (SeaWorld Entertainment Inc.), LIVN (LivaNova PLC), ITGR (Integer Holdings Corporation). Compare OM side-by-side with any of them on Quantisnow.How can I track OM on Quantisnow?
Quantisnow aggregates Outset Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow OM to receive live email and push alerts on every new disclosure.